Patents
Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
04/2014
04/29/2014US8710234 Amide derivatives, process for preparation thereof and use thereof as insecticide
04/29/2014US8710222 2,4-disubstituted pyrimidines useful as kinase inhibitors
04/29/2014US8710221 Process and intermediates for preparing lapatinib
04/29/2014US8710098 Group of amino substituted benzoyl derivatives and their preparation and their use
04/29/2014US8710044 Bicyclic azaheterocyclic carboxamides
04/29/2014US8709993 Quinazoline compounds and their use in perfume compositions
04/29/2014CA2655573C Therapeutic or prophylactic agent for multiple sclerosis
04/29/2014CA2637631C Pyrimidine compounds and uses thereof
04/29/2014CA2573976C Hiv inhibiting 5-carbo- or heterocyclic substituted pyrimidines
04/29/2014CA2570873C Pyrimidine urea derivatives as kinase inhibitors
04/24/2014WO2014062811A2 METHOD OF TREATING CANCER WITH MODULATORS OF SCFSkp2
04/24/2014WO2014062044A1 Fluorinated benzenesulfonamides as inhibitors of carbonic anhydrase
04/24/2014WO2014060900A1 Process for the preparation of voriconazole and analogues thereof
04/24/2014WO2014060588A1 2,3-dihydroquinazolin-4(1 h)-one derivatives for use in the treatment of viral infections
04/24/2014WO2014060586A1 New compounds having a protective activity against toxins with intracellular activity
04/24/2014WO2014060376A1 4-(ortho)-fluorophenyl-5-fluoropyrimidin-2-yl amines containing a sulfone group
04/24/2014WO2014060371A1 Inhibitors of syk
04/24/2014US20140113923 Novel antiviral therapies
04/24/2014US20140113922 Compounds
04/24/2014US20140113898 Bisarylsulfone and dialkylarylsulfone compounds as calcium channel blockers
04/23/2014EP2722328A1 Novel compounds with protective activity against toxins with intracellular action mode
04/23/2014EP2722047A1 2,3-dihydroquinazolin-4(1H)-one derivatives for use in the treatment of viral infections
04/23/2014CN103748106A Efficient peptide couplings and their use in the synthesis and isolation of cyclopenta (G) quinazoline trisodium salt
04/23/2014CN103748081A Quinazoline derivatives for the treatment of viral infections and further diseases
04/23/2014CN103739558A Method for preparing known impurities of gefitinib
04/23/2014CN103739557A Synthetic method of 4,6-dimethyl-2-methyl sulfonyl pyridine
04/23/2014CN103739556A Preparation method and detection method of 2,4-dibromopyrimidine
04/23/2014CN103739546A Four-hydrogen-bond fullerene supramolecular polymer with stripped morphology and preparation method thereof
04/23/2014CN103183644B Uracil zinc salt and application thereof as heat stabilizer for PVC
04/23/2014CN102675226B 3-substituted-1-methyl-quinazoline-2,4-dione compounds, preparation method and application thereof
04/22/2014US8703945 Process and intermediate compounds useful in the preparation of statins, particularly rosuvastatin
04/22/2014US8703944 Method for preparing rosuvastatin calcium intermediate
04/22/2014US8703785 2-aminopyrimidin-4-one and 2-aminopyridine derivatives both having BACE1-inhibiting activity
04/22/2014US8703782 Substituted indole derivatives
04/22/2014US8703768 Nitrogen containing heteroaryl compounds
04/22/2014US8703767 Substituted N-(3-(pyrimidin-4-yl)phenyl)acrylamide analogs as tyrosine receptor kinase BTK inhibitors
04/22/2014CA2623360C Squaric acid derivatives as inhibitors of histone deacetylase
04/22/2014CA2612227C Pyrimidine compounds
04/17/2014WO2014058747A1 5-phenoxy-3h-pyrimidin-4-one derivatives and their use as hiv reverse transcriptase inhibitors
04/17/2014WO2014057080A2 Cyclic amines
04/17/2014WO2014057078A1 Benzamides
04/17/2014WO2014056760A1 Hair dye agent comprising aminopyrimidine derivatives
04/17/2014WO2014056758A1 Hair dye agent comprising aminopyrimidine derivatives
04/17/2014WO2014036528A3 Agents useful for treating obesity, diabetes and related disorders
04/17/2014US20140107340 Benzamides
04/17/2014US20140107335 Cyclic Amines
04/17/2014US20140107160 Ccr9 inhibitors and methods of use thereof
04/17/2014US20140107134 Compounds for inflammation and immune-related uses
04/17/2014US20140107128 Heterocyclic compounds and uses thereof in the treatment of sexual disorders
04/17/2014US20140105920 Compositions and methods to treat disease characterized by cellular proliferation and angiogenesis
04/16/2014EP2719395A1 Adsorption of immunopotentiators to insoluble metal salts
04/16/2014EP2718270A2 Compositions and methods for the production of pyrimidine and pyridine compounds with btk inhibitory activity
04/16/2014CN103732578A Quinolinyl glucagon receptor modulators
04/16/2014CN103732067A Compounds,compositions and therapeutic uses thereof
04/16/2014CN103724331A Compound for treating cerebral palsy and use thereof
04/16/2014CN103724282A Synthesis method of quinazoline derivatives as pharmaceutical intermediate
04/16/2014CN103724281A Novel derivative of N-[5-(4-bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]ethoxy]-4-pyrimidinyl]-N'-propyl and application of novel derivative
04/16/2014CN103724280A Compound for treating cerebral palsy and use thereof
04/16/2014CN103724279A Portable synthesis method for preparing 2-methyl-4-amino-5-aminoethylpyrimidine through one-step cyclization reaction
04/16/2014CN103724278A Preparation method for tatin intermediate and derivatives thereof
04/16/2014CN103159684B Method for preparing 2-amino-4, 6-dimethoxypyrimidine
04/16/2014CN102617486B Process for preparing 6-chlorine-1,3-dimethyl uracil
04/16/2014CN102516182B Preparation method for 4-amino-6-alkoxyl pyrimidine compounds
04/16/2014CN102408380B 5-aminopyrimidine-thione compounds and preparation method thereof
04/16/2014CN102399197B 2-(2-hydroxy - substituted phenethyl sulfenyl]-3H-pyrimidin-4-ketone compounds and synthesis method and application thereof
04/16/2014CN102311395B Quinazoline ring substituted diphenylurea derivative and its purpose
04/16/2014CN101795566B Co-crystals of pyrimethanil and dithianon
04/15/2014US8697869 3-(heteroaryl-amino)-1,2,3,4-tetrahydro-9H-carbazole derivatives and their use as prostaglandin D2 receptor modulators
04/15/2014US8697865 Cyclic amide derivative, and its production and use
04/15/2014US8697717 Inhibitors of histone deacetylase
04/15/2014US8697714 Quinazolinone based fluorogenic probes
04/15/2014US8697697 Pyrazole derivatives as ERK inhibitors
04/15/2014US8697694 Substituted pyridine and pyrimidine derivatives and their use in treating viral infections
04/15/2014US8697687 Treating diseases mediated by blockade of the epithelial sodium channel with pyrazine-2-carboxamide derivatives
04/15/2014US8697685 Chemical compounds
04/15/2014US8697348 Mutations in the Bcr-Abl tyrosine kinase associated with resistance to STI-571
04/15/2014US8697256 Composition comprising phosphorescent compound and light emitting device using the composition
04/10/2014WO2014053694A1 N-prop-2-ynyl carboxamide derivatives and their use as trpa1 antagonists
04/10/2014WO2014053595A1 Acylaminopyrimidine derivatives for the treatment of viral infections and further diseases
04/10/2014WO2012118945A3 Fused bicyclic heterocycles useful as dipeptidyl peptidase-iv inhibitors
04/10/2014US20140100210 Guanidine compound
04/10/2014US20140100195 Heterobicyclic sphingosine 1-phosphate analogs
04/10/2014DE102012218459A1 Haarfärbemittel enthaltend Aminopyrimidinderivate Hair dyes containing aminopyrimidine derivatives
04/09/2014EP2716633A1 Quinazoline derivative as tyrosine-kinase inhibitor, preparation method therefor and application thereof
04/09/2014EP2716292A1 Cdc42 inhibitor and uses thereof
04/09/2014EP2714665A1 New 1-arylpiperazinic ligands of 5-ht7 receptor and use thereof
04/09/2014EP2714660A1 Neprilysin inhibitors
04/09/2014EP2713755A1 Cyclohexanone compounds and herbicides comprising the same
04/09/2014EP2713736A1 Novel immune system modulators
04/09/2014CN103717070A Novel immune system modulators
04/09/2014CN103709110A Preparation method of erlotinib hydrochloride key intermediate
04/09/2014CN103709109A Preparation method of sulfadimidine hydrosulfate
04/09/2014CN103709108A Production method of synthesizing 2-amino-4,6-dimethoxy pyrimidine
04/09/2014CN103709107A Novel crystal form of rosuvastatin methyl ester, and preparation method thereof
04/09/2014CN103709106A Stereoselectivity preparation method for Letairis
04/09/2014CN103709097A 1,3-substituted carbamide or thiourea compound, preparation method thereof, pharmaceutical composition and application
04/09/2014CN102698803B Ruthenium complex catalyst and preparation method and application thereof
04/09/2014CN102659692B Double-linked Erlotinib and preparation method thereof
04/09/2014CN102548965B Substituted amide compound
04/09/2014CN102464622B Substituted pyrimidine ammine compound and application thereof
1 ... 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 ... 427